Early Hepatitis Detection

Early Detection Hepatitis Test in Kathmandu — Screen Early Catch Silent Liver Infections Before They Cause Damage

Hepatitis B and C often cause no symptoms for years while silently damaging the liver. Early detection through screening enables treatment, prevents cirrhosis and stops transmission. Confidential testing at Thamel Clinic, Kathmandu.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

Important Safety Information

  • A positive hepatitis B surface antigen result indicates current infection — confirmatory testing is needed before treatment decisions.
  • A positive hepatitis C antibody test does not confirm current infection — an RNA test is required.
  • If you have been exposed to hepatitis B within the last 7 days, seek urgent care — post-exposure prophylaxis may prevent infection.
  • Never share needles, razors or personal items that may have blood on them — hepatitis B and C spread through blood.
  • If you develop jaundice, severe fatigue, abdominal swelling or confusion, seek urgent medical attention — these may indicate advanced liver disease.

Hepatitis in the Nepali Context

  • Significant disease burden — Nepal has substantial hepatitis B and C prevalence, particularly in certain populations; many infections remain undiagnosed.
  • Limited screening — hepatitis screening is not routine in Nepal outside specific programs; many people do not know their status.
  • Treatment access — hepatitis C treatment is available in Kathmandu but expensive; hepatitis B management is more established.
  • Blood safety — hepatitis screening is routine before blood transfusion in Nepal, but community transmission continues.
  • Risk factors — unsafe injections, transfusions before screening, multiple partners and certain occupations increase risk.
  • Confidential testing — stigma around hepatitis prevents many from seeking testing; confidential services address this barrier.

Why Early Hepatitis Detection Saves Lives

Hepatitis B and C are called "silent" infections because they often cause no symptoms for years or decades while progressively damaging the liver. Many people discover their infection only when they develop cirrhosis, liver failure or liver cancer — at which point treatment options are limited and outcomes are worse. Early detection through screening changes this trajectory completely.

The good news is that hepatitis is highly treatable when caught early. Hepatitis C is now curable with direct-acting antiviral medications — over 95% of patients achieve sustained virologic response (cure) with 8–12 weeks of treatment. Hepatitis B can be managed with antiviral therapy and monitoring to prevent progression to cirrhosis and liver cancer. Both conditions are far easier to treat before advanced liver damage occurs.

Early detection also prevents transmission. People who know their hepatitis status can take steps to protect partners, family members and — in the case of hepatitis B — newborns. Treatment reduces viral load, making transmission less likely. Vaccination protects susceptible family members. Early detection is both a personal health benefit and a public health benefit.

This page explains why early hepatitis detection matters, who should be screened, what tests are available, what results mean and how Thamel Clinic provides confidential early detection services in Kathmandu. Whether you have risk factors, symptoms or simply want peace of mind, early screening is one of the most important health investments you can make.

The Silent Nature of Hepatitis

Hepatitis B and C are often called "silent" infections because they typically cause no symptoms during the early stages. Acute hepatitis — the initial infection — may cause fever, fatigue, nausea, dark urine, jaundice (yellowing of skin and eyes) and abdominal pain, but many people experience mild or no symptoms at all and do not realize they are infected.

The danger is in the chronic phase. When hepatitis B or C becomes chronic — which happens in a significant percentage of cases — the virus continues to damage the liver silently for years or decades. The person may feel perfectly healthy while cirrhosis develops. By the time symptoms appear — fatigue, jaundice, abdominal swelling, confusion — the liver damage may be advanced and irreversible.

This is why screening is so important. You cannot rely on symptoms to tell you whether you have hepatitis. The only way to know is through blood testing. Early detection — before symptoms and before advanced liver damage — is the key to preventing serious complications.

  • Often asymptomatic for years while damaging the liver silently.
  • Acute symptoms (if any) are often mild — fever, fatigue, dark urine, jaundice.
  • Chronic phase may cause no symptoms until cirrhosis or liver cancer develops.
  • Cannot rely on symptoms — only blood testing reveals infection status.
  • Early detection prevents progression to advanced liver disease.

Silent progression

Hepatitis damages the liver for years without symptoms — early detection prevents complications.

Acute symptoms

Fever, fatigue, nausea, dark urine, jaundice — but many people have mild or no symptoms.

Chronic phase

May cause no symptoms until cirrhosis or liver cancer develops — screening is essential.

Testing is the only way

You cannot know your hepatitis status without blood testing — symptoms are unreliable.

Who Should Get Early Hepatitis Screening

Anyone with risk factors for hepatitis B or C should be screened. Risk factors include: people who inject drugs (even once), healthcare workers with needlestick exposure, people who received blood transfusions before screening was routine, people with multiple sexual partners, people born in regions with high hepatitis prevalence, people with HIV or other STDs, and anyone with abnormal liver function tests.

Family members of people with hepatitis B or C should also be tested — the virus can spread within households through shared razors, toothbrushes or other items with blood contact. Sexual partners of people with hepatitis B should be tested and vaccinated if negative.

Pregnant women should be screened for hepatitis B — the virus can be transmitted to the baby during delivery, but vaccination and treatment can prevent this. Hepatitis C screening is also recommended during pregnancy. People planning pregnancy, starting immunosuppressive therapy or undergoing certain medical procedures should also be screened.

  • People who inject drugs — even once — are at high risk.
  • Healthcare workers with needlestick or blood exposure.
  • People who received transfusions before screening was routine.
  • Multiple sexual partners or partners with hepatitis.
  • Born in regions with high hepatitis prevalence.
  • Family members of people with hepatitis B or C.
  • Pregnant women — screening protects mother and baby.
  • Anyone with abnormal liver function tests.

High-risk individuals

People who inject drugs, healthcare workers, transfusion recipients, multiple partners.

Family members

Household contacts of people with hepatitis B or C should be tested.

Pregnant women

Screening protects both mother and baby from vertical transmission.

Routine screening

Anyone with liver symptoms, abnormal tests or general health concerns.

Tests for Early Hepatitis Detection

Hepatitis B testing detects the hepatitis B surface antigen (HBsAg) — a marker of current infection. Additional tests include hepatitis B e antigen (HBV DNA) for viral activity, hepatitis B core antibody for past infection, and liver function tests (ALT, AST, bilirubin) to assess liver damage. These tests distinguish between acute and chronic infection and guide treatment decisions.

Hepatitis C testing begins with an antibody test that detects exposure to the virus. A positive antibody test requires confirmation with HCV RNA (PCR) testing to determine if the virus is still present — antibodies persist even after cure. Viral load testing measures the amount of virus and guides treatment monitoring.

Both tests require a simple blood draw. Results are typically available within 24–72 hours. At Thamel Clinic, testing is confidential with coded result access available — you can receive results privately without identity disclosure if preferred.

  • Hepatitis B — HBsAg detects current infection; additional markers assess activity.
  • Hepatitis C — antibody test + RNA confirmation distinguishes current from past infection.
  • Liver function tests — ALT, AST, bilirubin assess liver damage.
  • Simple blood draw — results within 24–72 hours.
  • Confidential testing — coded results available for privacy.

Hepatitis B panel

HBsAg, HBeAg, HBV DNA, liver function — comprehensive assessment of infection and liver health.

Hepatitis C antibody

Screens for HCV exposure — positive requires RNA confirmation.

HCV RNA (PCR)

Detects current infection and measures viral load — essential after positive antibody.

Liver function tests

ALT, AST, bilirubin, albumin — assess liver damage and disease activity.

Treatment When Hepatitis Is Caught Early

Hepatitis C caught early is highly treatable. Direct-acting antiviral medications cure over 95% of infections with 8–12 weeks of treatment. These medications have few side effects and are well-tolerated. Early treatment prevents progression to cirrhosis and liver cancer, and reduces transmission risk.

Hepatitis B caught early can be managed effectively. Antiviral medications suppress viral replication and reduce liver damage. Regular monitoring tracks disease progression and treatment response. Some people with early hepatitis B may clear the virus spontaneously; others need long-term antiviral therapy.

For both hepatitis B and C, early detection allows lifestyle interventions that slow disease progression — avoiding alcohol, maintaining healthy weight, managing diabetes and hepatitis risk factors, and getting vaccinated against hepatitis A if not already immune. These measures complement medical treatment.

  • Hepatitis C — direct-acting antivirals cure over 95% in 8–12 weeks.
  • Hepatitis B — antiviral therapy suppresses virus and reduces liver damage.
  • Early treatment prevents cirrhosis and liver cancer.
  • Reduced transmission risk — treatment lowers viral load.
  • Lifestyle interventions — alcohol avoidance, weight management, diabetes control.

Hepatitis C cure

Direct-acting antivirals cure over 95% of infections in 8–12 weeks — available in Kathmandu.

Hepatitis B management

Antiviral therapy and monitoring prevent progression to cirrhosis.

Preventing complications

Early treatment prevents cirrhosis, liver failure and liver cancer.

Lifestyle support

Alcohol avoidance, weight management and vaccination complement medical treatment.

Preventing Transmission After Detection

Once hepatitis is detected, preventing transmission to others becomes a priority. For hepatitis B, which spreads through blood and bodily fluids, partners and household contacts should be vaccinated if they are not already immune. Sexual partners should use barrier protection until vaccination confirms immunity.

For hepatitis C, which spreads primarily through blood contact, transmission prevention involves not sharing needles, razors or personal items, covering open wounds and ensuring medical procedures use sterile equipment. Sexual transmission of hepatitis C is less common but possible, especially with certain sexual practices.

Treatment itself reduces transmission risk — hepatitis C cure eliminates the virus entirely, and hepatitis B treatment reduces viral load significantly. Regular monitoring ensures treatment is working and viral load remains low. Partner notification and vaccination are important components of comprehensive care.

  • Hepatitis B — vaccinate partners and household contacts; barrier protection until immune.
  • Hepatitis C — avoid sharing needles, razors or items with blood contact.
  • Treatment reduces transmission — cure eliminates hepatitis C; treatment lowers hepatitis B viral load.
  • Partner notification — inform partners so they can test and vaccinate.
  • Regular monitoring — ensures treatment is working and viral load remains low.

Hepatitis B prevention

Vaccinate partners and household contacts; barrier protection until confirmed immunity.

Hepatitis C prevention

Avoid blood contact — no sharing needles, razors or personal items with blood exposure.

Treatment reduces spread

Cure eliminates hepatitis C; treatment significantly reduces hepatitis B transmission risk.

Partner protection

Notification and vaccination protect partners and family members.

Long-Term Monitoring and Follow-Up

Hepatitis B requires long-term monitoring even when well-controlled. Regular blood tests track viral load, liver function and disease progression. Some people need lifelong antiviral therapy; others may achieve sustained remission. Monitoring detects any signs of progression to cirrhosis or liver cancer early.

Hepatitis C after cure requires less intensive monitoring — most people who achieve sustained virologic response (SVR) are considered cured and need only occasional follow-up. However, those with advanced fibrosis or cirrhosis need ongoing surveillance for liver cancer even after cure.

Both conditions benefit from regular liver health monitoring — imaging (ultrasound) and blood tests (AFP for liver cancer screening) may be recommended for those with advanced disease. Lifestyle factors — alcohol avoidance, weight management, diabetes control — remain important throughout life.

  • Hepatitis B — long-term monitoring of viral load, liver function and disease progression.
  • Hepatitis C — minimal monitoring after cure; ongoing surveillance for advanced disease.
  • Liver cancer screening — imaging and AFP for those with cirrhosis.
  • Lifestyle factors — alcohol avoidance, weight management, diabetes control remain important.
  • Regular follow-up — ensures treatment is working and complications are caught early.

Hepatitis B monitoring

Regular viral load, liver function and disease progression assessment.

Hepatitis C post-cure

Minimal monitoring for most; ongoing surveillance for advanced disease.

Liver cancer screening

Imaging and blood tests for those with cirrhosis or advanced fibrosis.

Lifestyle throughout life

Alcohol avoidance, weight management and diabetes control remain essential.

Early Hepatitis Detection Services and Pricing

ServiceWhat It IncludesCost (NPR)
Hepatitis B Screening PanelHBsAg, anti-HBs, anti-HBc — detects current infection, immunity and past exposure.Rs. 1,500–3,000
Hepatitis C Antibody TestScreens for HCV exposure — positive requires RNA confirmation.Rs. 800–1,500
Hepatitis C RNA (PCR)Detects current hepatitis C infection and measures viral load.Rs. 3,000–6,000
Hepatitis B Viral LoadHBV DNA testing — measures amount of virus and guides treatment.Rs. 3,000–6,000
Liver Function PanelALT, AST, bilirubin, albumin, alkaline phosphatase — assesses liver health.Rs. 1,000–2,500
Complete Hepatitis PanelHepatitis B + C screening with liver function tests — comprehensive early detection.Rs. 3,000–5,000
Hepatitis VaccinationHepatitis A and/or B vaccination for those who test negative.Rs. 1,500–3,000 per dose
Confidential CounselingPrivate counseling before and after testing — result interpretation and treatment planning.Included
Hepatitis Treatment ReferralCoordination with specialists for hepatitis B or C treatment when needed.Referral

All testing is confidential. Prices are indicative; treatment costs are discussed separately based on individual needs.

Why Patients Choose Thamel Clinic for Early Hepatitis Detection

  • Early detection focus — screening designed to catch hepatitis before symptoms and complications.
  • Complete hepatitis testing — both hepatitis B and C with liver function assessment.
  • Modern laboratory — accurate testing with rapid results and proper confirmation.
  • Confidential service — private consultations with coded results available.
  • Treatment coordination — positive results connect to hepatitis specialists for treatment.
  • Vaccination available — hepatitis A and B vaccines for those who test negative.
  • Non-judgmental care — every patient treated with dignity regardless of how they may have been exposed.
  • Central Kathmandu location — easily accessible in Thamel for discreet visits.

Relevant Specialist Expertise

These clinicians provide care within their scope of practice at our clinic.

Portrait of Dr. Sushil Sitaula, Consultant in Internal Medicine

Dr. Sushil Sitaula

Consultant in Internal Medicine

MBBS
MD — Internal Medicine

Nepal Medical Council Registration No. 6973

Dr. Sushil Sitaula is a Consultant in Internal Medicine with a special interest in sexual health. He holds an MBBS and an MD in Internal Medicine and is registered with the Nepal Medical Council (Registration No. 6973).

Key Expertise

General Internal MedicineSexual HealthSexual HealthGeneral Internal Medicine

Frequently Asked Questions

Why is early hepatitis detection important?

Hepatitis B and C often cause no symptoms for years while damaging the liver. Early detection allows treatment before cirrhosis or liver cancer develops. Hepatitis C is curable; hepatitis B is manageable. Early detection also prevents transmission to others.

Who should get hepatitis screening?

Anyone with risk factors: people who inject drugs, healthcare workers with needlestick exposure, transfusion recipients before screening was routine, multiple sexual partners, family members of people with hepatitis, pregnant women, and anyone with abnormal liver tests or symptoms.

Can hepatitis be cured if detected early?

Hepatitis C is curable — direct-acting antivirals achieve cure in over 95% of cases. Hepatitis B cannot be completely cured but can be managed with antiviral therapy to prevent liver damage. Early detection makes treatment most effective.

What tests are used for early hepatitis detection?

Hepatitis B testing uses HBsAg and related markers. Hepatitis C testing uses antibody screening with RNA confirmation. Liver function tests assess damage. All require a simple blood draw with results in 24–72 hours.

How much does early hepatitis testing cost?

Hepatitis B panel Rs. 1,500–3,000; hepatitis C antibody Rs. 800–1,500; RNA confirmation Rs. 3,000–6,000; liver function Rs. 1,000–2,500. Complete panel Rs. 3,000–5,000. Transparent pricing with no hidden fees.

Is hepatitis testing confidential?

Yes. All testing at Thamel Clinic is confidential. Coded result access is available for those who prefer privacy. Results are only shared with your consent.

What happens if my hepatitis test is positive?

A positive result means you have hepatitis B or C — both are treatable. Hepatitis C is curable; hepatitis B is manageable. Confirmatory testing and staging determine the extent of infection. Confidential counseling and treatment coordination are provided.

Can I spread hepatitis to my family?

Hepatitis B can spread through household contact — shared razors, toothbrushes or items with blood. Hepatitis C spreads primarily through blood contact. Vaccination protects susceptible family members. Treatment reduces transmission risk.

Do I need to fast before hepatitis testing?

Hepatitis B and C tests do not require fasting. However, if liver function tests are included, fasting may be recommended. Your healthcare provider will advise before the test.

How often should I get hepatitis screening?

If you have ongoing risk factors, annual screening is recommended. If you have been treated and cured (hepatitis C) or are managing hepatitis B, regular monitoring is needed. Your provider will recommend the appropriate schedule.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Hepatology and infectious disease clinical reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current WHO and CDC hepatitis testing and treatment guidelines. This is general medical information; a registered clinician must assess each patient before treatment.

View clinic team and credentials

References

  1. Hepatitis B fact sheet — World Health Organization, 2024
  2. Hepatitis C fact sheet — World Health Organization, 2024
  3. Hepatitis — Symptoms and causes — Mayo Clinic, 2024

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now